Bharat Immunologicals Alerts
|Bharat Immunologicals appears to be very risky and stock price may revert if volatility continues|
|The company reported revenue of 1.28 B. Net Loss for the year was (53.46 M) with profit before overhead, payroll, taxes, and interest of 119 M. |
The company currently falls under 'Small-Cap' category with current market capitalization of 844.17 M.
The company has Profit Margin (PM) of (4.18) %
which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (5.13) %
which suggests for every $100 dollars of sales it generated a net operating loss of -0.05.
Book value of the company was currently as 8.21. The company recorded loss per share
. Bharat Immunologicals Biologicals Corp Ltd had not issued any dividends in recent years. Bharat Immunologicals & Biologicals Corporation Limited, a biotechnology company, manufactures and markets a range of pharmaceuticals solutions in India. For more info on BHARAT IMUNO(BSE please contact the company at 91 57 3223 8758 or go to http://www.bibcol.com.
Bharat Immunologicals Biologicals Corp Ltd has return on total asset (ROA) of (1.69) %
which means that it has lost $1.69 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (11.52) %
meaning that it generated substantial loss on money invested by shareholders.
Bharat Immunologicals Biologicals Corp Ltd shows Mean Deviation
of 2.62 and Risk Adjusted Performance
of 0.1091. Bharat Immunologicals technical analysis gives you the methodology to make use of historical prices
and volume patterns to determine a pattern that approximates the direction of the firm future prices. In plain English you can use this information to find out if the firm will indeed mirror its model of historical prices
and volume momentum or the prices will eventually revert. We found nineteen technical drivers
for Bharat Immunologicals Biologicals Corp Ltd which can be compared to its rivals. Please confirm Bharat Immunologicals Jensen Alpha
, Semi Variance
and the relationship
between Standard Deviation
and Value At Risk
to decide if Bharat Immunologicals is priced correctly providing market reflects its regular price of 32.3 per share.